MERITAGE PORTFOLIO MANAGEMENT: GSK position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MERITAGE PORTFOLIO MANAGEMENT on GSK, newest first. How the timeline and the estimate are built.
MERITAGE PORTFOLIO MANAGEMENT held 0 GSK shares at 2025-03-31 per its 13F-HR filed 2025-04-28.
the latest 13F is the newest step
- period ended2025-03-3113F 0 sharesChange vs previous 13F -157,102 shares
13F-HR 0000881432-25-000006 filed by MERITAGE PORTFOLIO MANAGEMENT
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2024-12-3113F 157,102 sharesChange vs previous 13F -2,544 shares
0.33% of the 13F portfolio, value $5,313,190.
13F-HR 0000881432-25-000002 filed by MERITAGE PORTFOLIO MANAGEMENT
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 159,646 sharesChange vs previous 13F -3,655 shares
0.4% of the 13F portfolio, value $6,526,000.
13F-HR 0000881432-24-000018 filed by MERITAGE PORTFOLIO MANAGEMENT
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-06-3013F 163,301 sharesChange vs previous 13F -2,209 shares
0.4% of the 13F portfolio, value $6,287,000.
13F-HR 0000881432-24-000011 filed by MERITAGE PORTFOLIO MANAGEMENT
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-03-3113F 165,510 sharesChange vs previous 13F not available
0.45% of the 13F portfolio, value $7,095,000.
13F-HR 0000881432-24-000006 filed by MERITAGE PORTFOLIO MANAGEMENT
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).